| Income Statement | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-09-30 |
|---|---|---|---|---|
| Total revenues | 17,062 | 18,418 | 18,514 | 19,546 |
| Cost of sales | 3,187 | 3,469 | 2,833 | 3,190 |
| Gross profit | 13,875 | 14,949 | 15,681 | 16,356 |
| Sales and marketing | 12,053 | 14,314 | 14,834 | 15,144 |
| General and administrative | 7,227 | 6,666 | 6,390 | 9,590 |
| Research and development | 3,748 | 5,117 | 6,284 | 5,428 |
| Total operating expenses | 23,028 | 26,097 | 27,508 | 30,162 |
| Operating loss | -9,153 | -11,148 | -11,827 | -13,806 |
| Interest expense | 1,268 | 1,252 | 1,233 | 1,359 |
| Other (expense) income, net | -2,751 | 2,484 | -791 | -1,068 |
| Loss before income taxes | -13,172 | -9,916 | -13,851 | -16,233 |
| Income tax (expense) benefit | 15 | 4 | 8 | -28 |
| Net loss | -13,187 | -9,920 | -13,859 | -16,205 |
| Basic | -0.46 | -0.38 | -0.53 | -0.62 |
| Diluted | -0.46 | -0.38 | -0.53 | -0.62 |
| Weighted average number of shares outstanding, basic, total | 28,393,445 | 26,367,548 | 26,253,565 | 25,983,929 |
| Weighted average number of shares outstanding, diluted, total | 28,393,445 | 26,367,548 | 26,253,565 | 25,983,929 |
AVITA Medical, Inc. (AVHHL)
AVITA Medical, Inc. (AVHHL)